cabazitaxel,lutetium lu 177 vipivotide tetraxetan
emcure,sanofi,novartis,ligand
['radio', 'therap ', 'crpc', 'cabazitaxel', 'ligand']
#asco22 news: therap study has shown no significant os boost with lupsma vs cabazitaxel in previously treated metastatic crpc, but &amp; team believe the radioligand therapy remains a valid option in this setting 
Medicine Matters #oncology publishes the latest news, commentary, research, and educational resources in a range of topics across oncology.